Teva Pharmaceutical Industries (TEVA) Dividends Paid - Common Growth (1y) (2010 - 2018)
Analysis
Teva Pharmaceutical Industries (TEVA) Dividends Paid - Common Growth (1y) (2010 - 2018) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.63 Bn | 38.97 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.19 Bn | 18.30 Bn | 1.46 Bn | 0.00% |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn | - |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.36 Bn | 520.30 Mn | 2.10 Bn | - |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | - |
| 8 | Amphastar Pharmaceuticals | 995.52 Mn | 705.40 Mn | 93.47 Mn | - |
| 9 | Fennec Pharmaceuticals | 404.35 Mn | 363.10 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 176.59 Mn | 176.59 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2018 | -96.53% |
| Dec 31, 2017 | -74.86% |
| Sep 30, 2017 | -63.82% |
| Jun 30, 2017 | 11.29% |
| Mar 31, 2017 | 12.70% |
| Dec 31, 2016 | 19.31% |
| Sep 30, 2016 | 18.47% |
| Jun 30, 2016 | 7.64% |
| Mar 31, 2016 | 5.86% |
| Dec 31, 2015 | 6.62% |
| Sep 30, 2015 | -2.38% |
| Jun 30, 2015 | -3.68% |
| Mar 31, 2015 | -0.34% |
| Dec 31, 2014 | -1.45% |
| Sep 30, 2014 | 11.36% |
| Jun 30, 2014 | 11.57% |
| Mar 31, 2014 | 3.56% |
| Dec 31, 2013 | 28.97% |
| Sep 30, 2013 | 11.39% |
| Jun 30, 2013 | 16.52% |